Clinical Read2026-06-01

Ivonescimab with Oxaliplatin + Fluorouracil + Leucovorin Calcium

Name: Ivonescimab with Oxaliplatin + Fluorouracil + Leucovorin Calcium
Start: 2026-06-01

Summit Therapeutics Inc.SMMT

Indication: Unresectable microsatellite stable (MSS) colorectal cancer (CRC)
Stage: phase2
Event: Phase 2